Veerhealth Care

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE882C01035
NSEID: NIYATILEAS
BSEID: 511523

INR

18.50

-0.13 (-0.7%)

BSENSE

Dec 17

BSE+NSE Vol: 45.88 k

{
  "main_header": {
    "sid": 631680,
    "name": "Veerhealth Care",
    "stock_name": "Veerhealth Care",
    "full_name": "Veerhealth Care Ltd",
    "name_url": "stocks-analysis/veerhealth-care",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "18.50",
    "chg": -0.13,
    "chgp": "-0.7%",
    "dir": -1,
    "prev_price": "18.63",
    "mcapval": "37.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 511523,
    "symbol": "NIYATILEAS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE882C01035",
    "curr_date": "Dec 17",
    "curr_time": "",
    "bse_nse_vol": "45.88 k",
    "exc_status": "Active",
    "traded_date": "Dec 17, 2025",
    "traded_date_str": "2025 12 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/veerhealth-care-631680-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Veerhealth Care’s Market Assessment Reflects Mixed Signals Amidst Financial and Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/veerhealth-care-downgraded-to-strong-sell-amid-technical-and-fundamental-concerns-3758389",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VeerhealthCare_mojoScore_3758389.png",
        "date": "2025-12-15 08:08:39",
        "description": "Veerhealth Care, a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation, influenced by a combination of technical indicators, financial trends, valuation considerations, and overall quality metrics. This article analyses the factors shaping the current market perspective on the stock, providing investors with a comprehensive understanding of its recent performance and outlook."
      },
      {
        "title": "Why is Veerhealth Care falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-veerhealth-care-fallingrising-3755652",
        "imagepath": "",
        "date": "2025-12-11 00:36:39",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Veerhealth Care's share price has been under pressure over the past three trading sessions, cumulatively losing 5.27% in returns. This recent decline contrasts with the stock's one-month performance, which remains positive at +5.60%, comfortably outperforming the Sensex's 1.02% gain over the same period. However, the year-to-date figures reveal a more challenging environment for the stock, with a 5.23% loss compared to the Sensex's 8.00% rise, indicating some volatility and profit-taking in recent months.</p>\n<p>Over longer horizons, Veerhealth Care has demonstrated robust growth, delivering a 76.64% return over three years and an impressive 367.00% gain over five years. These figures significantly outpace the Sensex's respective 35.72..."
      },
      {
        "title": "Veerhealth Care Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/veerhealth-care-stock-upgraded-from-strong-sell-to-sell-amid-mixed-financial-and-technical-signals-3732573",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VeerhealthCare_mojoScore_3732573.png",
        "date": "2025-11-27 08:07:34",
        "description": "Veerhealth Care, a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in market assessment driven by a combination of technical indicators and financial performance metrics. Despite recent positive quarterly results, the company’s long-term fundamentals and valuation metrics present a complex picture for investors navigating the current market environment."
      },
      {
        "title": "How has been the historical performance of Veerhealth Care?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-veerhealth-care-3731954",
        "imagepath": "",
        "date": "2025-11-26 22:43:56",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue Growth and Operating Performance</strong></p>\n<p>Veerhealth Care’s net sales have shown a consistent upward trend, rising from ₹5.98 crores in March 2019 to ₹16.67 crores in March 2025. This represents a near threefold increase over six years, reflecting the company’s expanding market presence and sales capabilities. The total operating income mirrors this growth, as other operating income remained nil throughout the period, indicating that revenue is primarily driven by core business activities.</p>\n<p>Despite this growth, the company’s operating profit margin excluding other income has experienced volatility. After a peak margin of 7.36% in 2019, margins declined sharply to negative territory in 2022, before recovering modestly to 2.76% in 2025. This fluctuation suggests challenges..."
      },
      {
        "title": "Are Veerhealth Care latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-veerhealth-care-latest-results-good-or-bad-3698334",
        "imagepath": "",
        "date": "2025-11-13 19:32:21",
        "description": "Veerhealth Care's latest financial results for Q2 FY26 present a complex picture of its operational performance. The company reported net sales of ₹3.98 crores, reflecting a contraction of 11.36% compared to the previous quarter and a significant decline of 22.72% year-on-year. This persistent revenue decline highlights ongoing challenges in maintaining market traction, particularly in a competitive pharmaceutical landscape.\n\nOn the profitability front, Veerhealth Care achieved a net profit of ₹0.25 crores, which represents a slight increase of 4.17% from the previous quarter, although it is down 16.67% from the same period last year. The profit after tax margin improved to 6.28%, up from 5.35% in Q1 FY26, indicating some progress in cost management. However, the reliance on other income, which accounted for a notable portion of the operating profit, raises concerns about the sustainability of these profita..."
      },
      {
        "title": "Veerhealth Care Q2 FY26: Profit Recovery Masks Deeper Revenue Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/veerhealth-care-q2-fy26-profit-recovery-masks-deeper-revenue-concerns-3698174",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VeerhealthCare_quaterlyResult_3698174.png",
        "date": "2025-11-13 09:31:17",
        "description": "Veerhealth Care Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹35.60 crores, reported a net profit of ₹0.25 crores in Q2 FY26, marking a marginal 4.17% quarter-on-quarter increase but a concerning 16.67% year-on-year decline. The stock, currently trading at ₹17.80, has struggled with a mildly bearish technical trend and remains 25.12% below its 52-week high of ₹23.77, reflecting investor scepticism about the company's ability to sustain profitable growth amidst persistent revenue volatility."
      },
      {
        "title": "How has been the historical performance of Veerhealth Care?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-veerhealth-care-3695282",
        "imagepath": "",
        "date": "2025-11-13 00:14:34",
        "description": "Answer:\nThe historical performance of Veerhealth Care shows a fluctuating trend in key financial metrics over the years.\n\nBreakdown:\nVeerhealth Care's net sales have shown a steady increase from INR 5.98 crore in March 2019 to INR 16.67 crore in March 2025, with a notable rise from INR 13.22 crore in March 2024. The total operating income followed a similar trajectory, reaching INR 16.67 crore in March 2025. Total expenditure, excluding depreciation, also rose to INR 16.21 crore in March 2025, up from INR 12.61 crore in the previous year. Operating profit (PBDIT) was INR 1.68 crore in March 2025, a decrease from INR 2.00 crore in March 2024. Profit before tax was INR 0.51 crore in March 2025, down from INR 1.28 crore in March 2024, while profit after tax slightly decreased to INR 0.39 crore from INR 0.41 crore. The company's total assets increased to INR 33.77 crore in March 2025, compared to INR 28.12 cror..."
      },
      {
        "title": "How has been the historical performance of Veerhealth Care?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-veerhealth-care-3693848",
        "imagepath": "",
        "date": "2025-11-12 23:15:37",
        "description": "Answer:\nThe historical performance of Veerhealth Care shows a fluctuating trend in its financial metrics over the years, with notable changes in revenue and profit margins.\n\nBreakdown:\nVeerhealth Care's net sales have increased from 9.63 Cr in Mar'22 to 16.67 Cr in Mar'25, reflecting a strong growth trajectory. Total operating income followed a similar pattern, rising from 9.63 Cr in Mar'22 to 16.67 Cr in Mar'25. The company's total expenditure also increased, reaching 16.21 Cr in Mar'25 from 10.45 Cr in Mar'22. Operating profit, excluding other income, was 0.46 Cr in Mar'25, down from 0.61 Cr in Mar'24, while the overall operating profit (PBDIT) was 1.68 Cr in Mar'25, a decrease from 2.00 Cr in Mar'24. Profit before tax showed a decline to 0.51 Cr in Mar'25 from 1.28 Cr in Mar'24, and profit after tax was 0.39 Cr in Mar'25, slightly down from 0.41 Cr in Mar'24. The company's total assets grew to 33.77 Cr i..."
      },
      {
        "title": "Veerhealth Care Faces Mixed Technical Signals Amidst Financial Challenges and Recent Growth",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/veerhealth-care-stock-downgraded-to-strong-sell-amid-bearish-trends-3688569",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VeerhealthCare_mojoScore_3688569.png",
        "date": "2025-11-11 08:25:49",
        "description": "Veerhealth Care, a microcap in the Pharmaceuticals & Biotechnology sector, has recently adjusted its evaluation score, reflecting a shift in technical trends. Despite reporting positive financial performance for Q1 FY25-26, the company faces challenges with operating losses and low profitability, contributing to its underperformance compared to the broader market."
      }
    ],
    "total": 140,
    "sid": "631680",
    "stock_news_url": "https://www.marketsmojo.com/news/veerhealth-care-631680"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "08-Dec-2025",
      "details": "Revised intimation under Regulation 30 of SEBI (LODR) Regulations 2015-Analysts/Institutional Investors Meeting on Thursday December 112025 from 2pm-3pm.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "08-Dec-2025",
      "details": "Pursuant to Regulation 30 of the SEBI (LODR) Regulations2015 we wish to inform that the management team of the company shall be participating in Q3 FY2025-26 earnings call scheduled on Thursday December 11 2025 at 2.00pm 9IST) hosted by Kirin advisors.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
      "datetime": "27-Nov-2025",
      "details": "We are pleased to inform that after completion of initial supply order to one of Indias leading Company in FMCG products Company has received fresh order for manufacturing and supply of personal care range of products under private label category. This new order represents a significant opportunity for the Company and we anticipate additional growth in turnover.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Veerhealth Care Ltd has announced <strong>10:1</strong> stock split, ex-date: 29 Nov 16",
          "dt": "2016-11-29",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Veerhealth Care Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 22 Sep 23",
          "dt": "2023-09-22",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Veerhealth Care’s Market Assessment Reflects Mixed Signals Amidst Financial and Technical Shifts

2025-12-15 08:08:39

Veerhealth Care, a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation, influenced by a combination of technical indicators, financial trends, valuation considerations, and overall quality metrics. This article analyses the factors shaping the current market perspective on the stock, providing investors with a comprehensive understanding of its recent performance and outlook.

Why is Veerhealth Care falling/rising?

2025-12-11 00:36:39

Recent Price Movement and Market Context

Veerhealth Care's share price has been under pressure over the past three trading sessions, cumulatively losing 5.27% in returns. This recent decline contrasts with the stock's one-month performance, which remains positive at +5.60%, comfortably outperforming the Sensex's 1.02% gain over the same period. However, the year-to-date figures reveal a more challenging environment for the stock, with a 5.23% loss compared to the Sensex's 8.00% rise, indicating some volatility and profit-taking in recent months.

Over longer horizons, Veerhealth Care has demonstrated robust growth, delivering a 76.64% return over three years and an impressive 367.00% gain over five years. These figures significantly outpace the Sensex's respective 35.72...

Veerhealth Care Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals

2025-11-27 08:07:34

Veerhealth Care, a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in market assessment driven by a combination of technical indicators and financial performance metrics. Despite recent positive quarterly results, the company’s long-term fundamentals and valuation metrics present a complex picture for investors navigating the current market environment.

How has been the historical performance of Veerhealth Care?

2025-11-26 22:43:56

Revenue Growth and Operating Performance

Veerhealth Care’s net sales have shown a consistent upward trend, rising from ₹5.98 crores in March 2019 to ₹16.67 crores in March 2025. This represents a near threefold increase over six years, reflecting the company’s expanding market presence and sales capabilities. The total operating income mirrors this growth, as other operating income remained nil throughout the period, indicating that revenue is primarily driven by core business activities.

Despite this growth, the company’s operating profit margin excluding other income has experienced volatility. After a peak margin of 7.36% in 2019, margins declined sharply to negative territory in 2022, before recovering modestly to 2.76% in 2025. This fluctuation suggests challenges...

Are Veerhealth Care latest results good or bad?

2025-11-13 19:32:21

Veerhealth Care's latest financial results for Q2 FY26 present a complex picture of its operational performance. The company reported net sales of ₹3.98 crores, reflecting a contraction of 11.36% compared to the previous quarter and a significant decline of 22.72% year-on-year. This persistent revenue decline highlights ongoing challenges in maintaining market traction, particularly in a competitive pharmaceutical landscape. On the profitability front, Veerhealth Care achieved a net profit of ₹0.25 crores, which represents a slight increase of 4.17% from the previous quarter, although it is down 16.67% from the same period last year. The profit after tax margin improved to 6.28%, up from 5.35% in Q1 FY26, indicating some progress in cost management. However, the reliance on other income, which accounted for a notable portion of the operating profit, raises concerns about the sustainability of these profita...

Veerhealth Care Q2 FY26: Profit Recovery Masks Deeper Revenue Concerns

2025-11-13 09:31:17

Veerhealth Care Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹35.60 crores, reported a net profit of ₹0.25 crores in Q2 FY26, marking a marginal 4.17% quarter-on-quarter increase but a concerning 16.67% year-on-year decline. The stock, currently trading at ₹17.80, has struggled with a mildly bearish technical trend and remains 25.12% below its 52-week high of ₹23.77, reflecting investor scepticism about the company's ability to sustain profitable growth amidst persistent revenue volatility.

How has been the historical performance of Veerhealth Care?

2025-11-13 00:14:34

Answer: The historical performance of Veerhealth Care shows a fluctuating trend in key financial metrics over the years. Breakdown: Veerhealth Care's net sales have shown a steady increase from INR 5.98 crore in March 2019 to INR 16.67 crore in March 2025, with a notable rise from INR 13.22 crore in March 2024. The total operating income followed a similar trajectory, reaching INR 16.67 crore in March 2025. Total expenditure, excluding depreciation, also rose to INR 16.21 crore in March 2025, up from INR 12.61 crore in the previous year. Operating profit (PBDIT) was INR 1.68 crore in March 2025, a decrease from INR 2.00 crore in March 2024. Profit before tax was INR 0.51 crore in March 2025, down from INR 1.28 crore in March 2024, while profit after tax slightly decreased to INR 0.39 crore from INR 0.41 crore. The company's total assets increased to INR 33.77 crore in March 2025, compared to INR 28.12 cror...

How has been the historical performance of Veerhealth Care?

2025-11-12 23:15:37

Answer: The historical performance of Veerhealth Care shows a fluctuating trend in its financial metrics over the years, with notable changes in revenue and profit margins. Breakdown: Veerhealth Care's net sales have increased from 9.63 Cr in Mar'22 to 16.67 Cr in Mar'25, reflecting a strong growth trajectory. Total operating income followed a similar pattern, rising from 9.63 Cr in Mar'22 to 16.67 Cr in Mar'25. The company's total expenditure also increased, reaching 16.21 Cr in Mar'25 from 10.45 Cr in Mar'22. Operating profit, excluding other income, was 0.46 Cr in Mar'25, down from 0.61 Cr in Mar'24, while the overall operating profit (PBDIT) was 1.68 Cr in Mar'25, a decrease from 2.00 Cr in Mar'24. Profit before tax showed a decline to 0.51 Cr in Mar'25 from 1.28 Cr in Mar'24, and profit after tax was 0.39 Cr in Mar'25, slightly down from 0.41 Cr in Mar'24. The company's total assets grew to 33.77 Cr i...

Veerhealth Care Faces Mixed Technical Signals Amidst Financial Challenges and Recent Growth

2025-11-11 08:25:49

Veerhealth Care, a microcap in the Pharmaceuticals & Biotechnology sector, has recently adjusted its evaluation score, reflecting a shift in technical trends. Despite reporting positive financial performance for Q1 FY25-26, the company faces challenges with operating losses and low profitability, contributing to its underperformance compared to the broader market.

View All News

Announcement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

08-Dec-2025 | Source : BSE

Revised intimation under Regulation 30 of SEBI (LODR) Regulations 2015-Analysts/Institutional Investors Meeting on Thursday December 112025 from 2pm-3pm.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

08-Dec-2025 | Source : BSE

Pursuant to Regulation 30 of the SEBI (LODR) Regulations2015 we wish to inform that the management team of the company shall be participating in Q3 FY2025-26 earnings call scheduled on Thursday December 11 2025 at 2.00pm 9IST) hosted by Kirin advisors.

Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

27-Nov-2025 | Source : BSE

We are pleased to inform that after completion of initial supply order to one of Indias leading Company in FMCG products Company has received fresh order for manufacturing and supply of personal care range of products under private label category. This new order represents a significant opportunity for the Company and we anticipate additional growth in turnover.